Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone

BACKGROUND: Established heart failure in thalassaemia major has a poor prognosis and optimal management remains unclear. METHODS: A 1 year prospective study comparing deferoxamine (DFO) monotherapy or when combined with deferiprone (DFP) for patients with left ventricular ejection fraction (LVEF) &l...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Porter, John B, Wood, John, Olivieri, Nancy, Vichinsky, Elliott P, Taher, Ali, Neufeld, Ellis, Giardina, Patricia, Thompson, Alexis, Moore, Blaine, Evans, Patricia, Kim, Hae-Young, Macklin, Eric A, Trachtenberg, Felicia
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669105/
https://ncbi.nlm.nih.gov/pubmed/23688265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1532-429X-15-38
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki